magNews
2022 list of China's most socially impactful startups
-
CorporateMoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held 2024-06-24
-
CorporateNMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
-
CorporatemagAssist ECMO approved in the Transformation of Scientific and Technological Achievements Special Fund 2023-08-28
-
Medical UpdatesFirst Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-08-23
-
CorporatemagAssist Attains Recognition as the Most Innovative Medical Device Product of 2023 2023-08-21
-
CorporatemagAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device 2023-08-17
-
CorporateFDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17
-
CorporateThe Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth 2023-07-28
-
CorporateBreathMo®: The New Generation ECMO system Revealed at ASAIO Conference 2023-07-22
-
CorporateMoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
- Technology
- Patent
- Fluid Dynamics
- Full Magnetic Levitated Rotor
- Mechatronics
- Product Manufacturing
- Artificial Hearts
WeChat
Copyright © 2022-2026 magAssist Co., Ltd. All Rights Reserved
